Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
603939.SS
STRONG BUYGet insider-trade alertsYifeng Pharmacy Chain Co., Ltd. · Healthcare · China · $3.2B · Avg Vol: $36M/d
COMPANY DESCRIPTION
Yifeng Pharmacy Chain Co., Ltd. operates a large-scale retail pharmacy chain selling pharmaceuticals, traditional Chinese medicines, and nutritional supplements. The company is one of China's top pharmacy chains with a dense regional network in Central and Southern China, driving high regional brand loyalty and purchasing power. It is a leading consolidator in the Chinese retail pharmacy sector, utilizing a highly efficient regional expansion and digital healthcare strategy.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9B | 3.3B | 3.5B | 3.6B | 7.1% | 3.6B | 3.9B | 4.3B | 9.0% |
| EPS | 0.15 | 0.17 | 0.19 | 0.20 | 9.5% | 0.21 | — | — | — |
| Shares | 1.2B | 1.2B | 1.2B | 1.2B | -0.0% | 1.2B | — | — | — |
| Debt | 509.2M | 559.3M | 777.8M | 648.7M | 8.4% | 629.8M | — | — | — |
| Equity | 1.3B | 1.4B | 1.6B | 1.7B | 10.8% | — | — | — | — |
| Op CF | 577.4M | 681.0M | 621.7M | 494.6M | -5.0% | 486.1M | — | — | — |
| Inv CF | -187.6M | -438.9M | -531.5M | -210.1M | — | — | — | — | — |
| Fin CF | -243.8M | -308.3M | -135.5M | -365.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 603939.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 603939.SS | Yifeng Pharmacy Chain Co., Ltd.(you) | $3.2B | 98 | STRONG BUY |
| 603233.SS | DaShenLin Pharmaceutical Group Co., Ltd. | $2.5B | 99 | STRONG BUY |
| 603883.SS | LBX Pharmacy Chain Joint Stock Company | $1.2B | 93 | STRONG BUY |
| 002727.SZ | Yixintang Pharmaceutical Group Co., Ltd. | $852M | 95 | STRONG BUY |
| 6618.HK | JD Health International Inc. | $13.0B | 84 | STRONG BUY |
| 301408.SZ | Anhui Huaren Health Pharmaceutical Co., Ltd. | $835M | 72 | BUY |
| 9885.HK | YSB Inc. | $356M | 77 | BUY |
| 002788.SZ | Luyan Pharma Co.,Ltd. | $575M | 53 | HOLD |
| 301017.SZ | ShuYu Civilian Pharmacy Corp., Ltd. | $783M | 41 | HOLD |
| 600566.SS | Hubei Jumpcan Pharmaceutical Co., Ltd. | $3.4B | 98 | STRONG BUY |
Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%